{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:49:33Z","timestamp":1789382973024,"version":"build-2803163510"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:italic>Mycobacterium bovis<\/jats:italic>\n            BCG is one of the most commonly administered vaccines. Complications, including disseminated BCG disease, are rare but increasingly reported in immunodeficient children. There is growing recognition of the importance of differences between BCG vaccine strains. We determined the susceptibilities of five genetically distinct BCG vaccine strains to 12 antituberculous drugs.\n          <\/jats:p>","DOI":"10.1128\/aac.01302-08","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T00:26:04Z","timestamp":1225153564000},"page":"316-318","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":99,"title":["Susceptibility of\n            <i>Mycobacterium bovis<\/i>\n            BCG Vaccine Strains to Antituberculous Antibiotics"],"prefix":"10.1128","volume":"53","author":[{"given":"Nicole","family":"Ritz","sequence":"first","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"},{"name":"Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"},{"name":"Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Connell","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"},{"name":"Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Sievers","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Reference Laboratories, North Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Robins-Browne","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Australia"},{"name":"Department of Microbiology and Immunology, The University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"},{"name":"Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Australia"},{"name":"Murdoch Children's Research Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00561-08"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8284673"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5419.1520"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.143-150.2004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000052378","volume":"37","year":"2000","unstructured":"Durek, C., S. Rusch-Gerdes, D. Jocham, and A. Bohle. 2000. Sensitivity of BCG to modern antibiotics. Eur. Urol.37(Suppl. 1):21-25.","journal-title":"Eur. Urol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00006454-200106000-00020","volume":"20","year":"2001","unstructured":"Goraya, J. S., and V. S. Virdi. 2001. Treatment of Calmette-Guerin bacillus adenitis: a metaanalysis. Pediatr. Infect. Dis. J.20:632-634.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.07.020"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","volume":"42","year":"2006","unstructured":"Hesseling, A. C., H. Rabie, B. J. Marais, M. Manders, M. Lips, H. S. Schaaf, R. P. Gie, M. F. Cotton, P. D. van Helden, R. M. Warren, and N. Beyers. 2006. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin. Infect. Dis.42:548-558.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.inf.0000126593.21006.ac","volume":"23","year":"2004","unstructured":"Hesseling, A. C., H. S. Schaaf, T. Victor, N. Beyers, B. J. Marais, M. F. Cotton, I. Wiid, R. P. Gie, P. van Helden, and R. M. Warren. 2004. Resistant Mycobacterium bovis bacillus Calmette-Guerin disease: implications for management of bacillus Calmette-Guerin disease in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J.23:476-479.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_11_2","first-page":"468","volume":"90","year":"1964","unstructured":"Hok, T. T. 1964. A comparative study of the susceptibility to ethionamide, thiosemicarbazone, and isoniazid of tubercle bacilli from patients never treated with ethionamide or thiosemicarbazone. Am. Rev. Respir. Dis.90:468-469.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.811-818.2006"},{"key":"e_1_3_2_13_2","first-page":"47","volume":"63","year":"1988","unstructured":"Lotte, A., O. Wasz-Hockert, N. Poisson, H. Engbaek, H. Landmann, U. Quast, B. Andrasofszky, L. Lugosi, I. Vadasz, P. Mihailescu, et al. 1988. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull. Int. Union Tuberc. Lung Dis.63:47-59.","journal-title":"Bull. Int. Union Tuberc. Lung Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(08)61318-5","volume":"372","year":"2008","unstructured":"Mak, T. K., A. C. Hesseling, G. D. Hussey, and M. F. Cotton. 2008. Making BCG vaccination programmes safer in the HIV era. Lancet372:786-787.","journal-title":"Lancet"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jac\/46.4.565","volume":"46","year":"2000","unstructured":"Rastogi, N., K. S. Goh, M. Berchel, and A. Bryskier. 2000. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG. J. Antimicrob. Chemother.46:565-570.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2848-2852.2000"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.7.1610"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2008.00118.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.688-692.2006"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.052175"},{"key":"e_1_3_2_21_2","first-page":"1334","volume":"11","year":"2007","unstructured":"Shishido, Y., S. Mitarai, K. Otomo, M. Seki, A. Sato, I. Yano, A. Koyama, and T. Hattori. 2007. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain. Int. J. Tuberc. Lung Dis.11:1334-1338.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/338462","volume":"34","year":"2002","unstructured":"Turnbull, F. M., P. B. McIntyre, H. M. Achat, H. Wang, R. Stapledon, M. Gold, and M. A. Burgess. 2002. National study of adverse reactions after vaccination with bacille Calmette-Guerin. Clin. Infect. Dis.34:447-453.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_23_2","first-page":"147","volume":"109","year":"1974","unstructured":"Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis.109:147-151.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_24_2","first-page":"244","volume":"80","year":"2005","unstructured":"World Health Organization. 2005. Isoniazid resistance of bacille Calmette-Guerin strains. Wkly. Epidemiol. Rec.80:244.","journal-title":"Wkly. Epidemiol. Rec."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01302-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01302-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:47:38Z","timestamp":1645472858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01302-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1128\/AAC.01302-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01302-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"2008-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}